Showing results (931-940 of 943) with videos related to

Sort By:
Pageof 95
Neurology|February 18, 2021
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENTAnthony A Amato, Michael G Hanna, Pedro M Machado, et al.
International Journal of Molecular Sciences|April 13, 2023
Photobiomodulation Reduces the Cytokine Storm Syndrome Associated with COVID-19 in the Zebrafish ModelIvana F Rosa, Ana P B Peçanha, Tábata R B Carvalho, et al.
Frontiers in Immunology|February 11, 2025
Plasma IL-17A is increased in patients with critical MIS-C and associated to in-hospital mortalityEmmerson C F de Farias, Luciana M P P do Nascimento, Manoel J C Pavão Junior, et al.
Annals of the Rheumatic Diseases|February 14, 2023
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesPedro M Machado, Martin Schäfer, Satveer K Mahil, et al.
Scientific Reports|March 6, 2024
Factors associated to mortality in children with critical COVID-19 and multisystem inflammatory syndrome in a resource-poor settingEmmerson C F de Farias, Manoel J C Pavão Junior, Susan C D de Sales, et al.
Rheumatology (Oxford, England)|September 20, 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination statusSinead Maguire, Samar Al-Emadi, Paula Alba, et al.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
Pageof 95